FDA applicant
Exo Imaging
FDA records 4 decisions for Exo Imaging (Santa Clara, CA) from 2021 to 2026: 4 510(k) clearances. Most are in product codes QIH (Automated Radiological Image Processing Software) and IYN (System, Imaging, Pulsed Doppler, Ultrasonic). Since 2016 its 510(k)s took a median of 103 days from receipt to decision, against 118 for FDA’s reviews in the same codes and years. Its devices cite 4 predicates, 2 of them its own earlier devices. No recall is linked to its devices.
FDA’s records also spell it “Exo Imaging, Inc.”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Exo Imaging’s devices, and how often a recall has named them.
FDA decisions per year
1in 2024
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2021.
Planning a device like Exo Imaging’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report